NWU Institutional Repository

Cellular bioenergetics is impaired in patients with chronic fatigue syndrome

Loading...
Thumbnail Image

Date

Authors

Tomas, Cara
Elson, Joanna
Brown, Audrey
Strassheim, Victoria
Newton, Julia

Supervisors

Journal Title

Journal ISSN

Volume Title

Publisher

PLOS

Record Identifier

Abstract

Chronic fatigue syndrome (CFS) is a highly debilitating disease of unknown aetiology. Abnormalities in bioenergetic function have been cited as one possible cause for CFS. Preliminary studies were performed to investigate cellular bioenergetic abnormalities in CFS patients. A series of assays were conducted using peripheral blood mononuclear cells (PBMCs) from CFS patients and healthy controls. These experiments investigated cellular patterns in oxidative phosphorylation (OXPHOS) and glycolysis. Results showed consistently lower measures of OXPHOS parameters in PBMCs taken from CFS patients compared with healthy controls. Seven key parameters of OXPHOS were calculated: basal respiration, ATP production, proton leak, maximal respiration, reserve capacity, non-mitochondrial respiration, and coupling efficiency. While many of the parameters differed between the CFS and control cohorts, maximal respiration was determined to be the key parameter in mitochondrial function to differ between CFS and control PBMCs due to the consistency of its impairment in CFS patients found throughout the study (p 0.003). The lower maximal respiration in CFS PBMCs suggests that when the cells experience physiological stress they are less able to elevate their respiration rate to compensate for the increase in stress and are unable to fulfil cellular energy demands. The metabolic differences discovered highlight the inability of CFS patient PBMCs to fulfil cellular energetic demands both under basal conditions and when mitochondria are stressed during periods of high metabolic demand

Sustainable Development Goals

Description

Keywords

Citation

Tomas, C. et al. 2017. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE, 12(10): Article no e0186802. [https://doi.org/10.1371/journal.pone.0186802]

Endorsement

Review

Supplemented By

Referenced By